Patient selection for the surgical treatment of resectable colorectal liver metastases

Advances in surgery and chemotherapy regimens have increased the long‐term survival of patients with colorectal liver metastases (CRLM). Although liver resection remains an essential part of any curative strategy for resectable CRLM, chemotherapy regimens have also improved the long‐term outcomes. H...

Full description

Saved in:
Bibliographic Details
Published in:Journal of surgical oncology 2017-02, Vol.115 (2), p.213-220
Main Authors: Araujo, Raphael L.C., Riechelmann, Rachel P., Fong, Yuman
Format: Article
Language:English
Subjects:
chemotherapy
colorectal liver metastases
Colorectal Neoplasms - pathology
Colorectal Neoplasms - surgery
Hepatectomy
Humans
Liver Neoplasms - secondary
Liver Neoplasms - surgery
long‐term outcomes
Patient Selection
surgery
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Advances in surgery and chemotherapy regimens have increased the long‐term survival of patients with colorectal liver metastases (CRLM). Although liver resection remains an essential part of any curative strategy for resectable CRLM, chemotherapy regimens have also improved the long‐term outcomes. However, the optimal timing for chemotherapy regimens remains unclear. Thus, this review addressed key points to aid the decision‐making process regarding the timing of chemotherapy and surgery for patients with resectable CRLM. J. Surg. Oncol. 2017;115:213–220. © 2016 Wiley Periodicals, Inc.
ISSN:0022-4790
1096-9098
DOI:10.1002/jso.24482